Grifols SA (GRFS)
9.545
+0.48
(+5.24%)
USD |
NASDAQ |
Nov 14, 16:00
9.545
0.00 (0.00%)
After-Hours: 17:59
Grifols Price to Book Value: 1.086 for Nov. 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 1.032 |
| November 12, 2024 | 1.035 |
| November 11, 2024 | 1.060 |
| November 08, 2024 | 1.079 |
| November 07, 2024 | 1.080 |
| November 06, 2024 | 1.029 |
| November 05, 2024 | 1.057 |
| November 04, 2024 | 1.001 |
| November 01, 2024 | 1.006 |
| October 31, 2024 | 0.9884 |
| October 30, 2024 | 0.9975 |
| October 29, 2024 | 0.9327 |
| October 28, 2024 | 0.9486 |
| October 25, 2024 | 0.9929 |
| October 24, 2024 | 1.008 |
| October 23, 2024 | 1.004 |
| October 22, 2024 | 1.003 |
| October 21, 2024 | 0.9748 |
| October 18, 2024 | 0.9838 |
| October 17, 2024 | 0.977 |
| October 16, 2024 | 0.9657 |
| October 15, 2024 | 0.9679 |
| October 14, 2024 | 0.9759 |
| October 11, 2024 | 0.977 |
| October 10, 2024 | 0.9816 |
| Date | Value |
|---|---|
| October 09, 2024 | 0.985 |
| October 08, 2024 | 0.9964 |
| October 07, 2024 | 1.01 |
| October 04, 2024 | 1.015 |
| October 03, 2024 | 1.018 |
| October 02, 2024 | 1.006 |
| October 01, 2024 | 1.004 |
| September 30, 2024 | 1.01 |
| September 27, 2024 | 1.015 |
| September 26, 2024 | 0.9965 |
| September 25, 2024 | 0.9818 |
| September 24, 2024 | 0.9863 |
| September 23, 2024 | 0.9977 |
| September 20, 2024 | 1.015 |
| September 19, 2024 | 1.029 |
| September 18, 2024 | 0.9908 |
| September 17, 2024 | 1.009 |
| September 16, 2024 | 1.048 |
| September 13, 2024 | 1.050 |
| September 12, 2024 | 1.033 |
| September 11, 2024 | 1.044 |
| September 10, 2024 | 0.9534 |
| September 09, 2024 | 0.9716 |
| September 06, 2024 | 0.9625 |
| September 05, 2024 | 1.007 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5767
Minimum
Mar 06 2024
3.246
Maximum
Feb 21 2020
1.419
Average
1.208
Median
Mar 08 2022
Price to Book Value Benchmarks
| Cellectis SA | 1.469 |
| Adaptimmune Therapeutics PLC | 1.567 |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals PLC | 0.2536 |
| Verona Pharma PLC | 22.17 |
Price to Book Value Related Metrics
| PE Ratio | 30.08 |
| PS Ratio | 0.8758 |
| PEG Ratio | 6.599 |
| Price | 9.545 |
| Earnings Yield | 3.32% |
| Market Cap | 6.487B |
| PEGY Ratio | 6.599 |
| Operating PE Ratio | 5.702 |
| Normalized PE Ratio | 27.45 |